stockrow
Saturday 7 November 2026
Export NVCT’s income statement to Excel — free account
Nuvectis Pharma, Inc.
NVCT Healthcare Biotechnology
- EPS
- −131.9%
- Free cash flow
- −34.6%
Quarter to September 2026, against a year earlier
20.81
3.05
+17.17%
Follow NVCT
Alert me
A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | |
|---|---|---|---|---|---|---|
Cash and Short Term Investments |
31.63 | 18.53 | 19.13 | 19.99 | 5.74 | — |
Other current assets |
0.08 | 0.07 | 0.06 | 0.41 | 0.09 | — |
Total current assets |
31.71 | 18.61 | 19.19 | 20.41 | 5.83 | — |
Total non-current assets |
— | — | — | — | 0.82 | — |
Total Assets |
31.71 | 18.61 | 19.19 | 20.41 | 6.66 | — |
Accounts Payable |
6.27 | 2.50 | 2.77 | 2.91 | 1.06 | 0.01 |
Accrued Expenses |
0.12 | 0.84 | 0.42 | 0.45 | 0.40 | — |
Total current liabilities |
13.30 | 8.89 | 6.98 | 6.19 | 2.42 | 0.01 |
Liabilities (Preferred Stock) |
— | — | — | — | 15.25 | — |
Total non-current liabilities |
— | — | — | — | 15.25 | — |
Total liabilities |
13.30 | 8.89 | 6.98 | 6.19 | 17.67 | 0.01 |
Additional Paid In Capital |
118.10 | 82.96 | 66.45 | 46.20 | 1.89 | — |
Retained Earnings |
(99.69) | (73.24) | (54.24) | (31.98) | (12.90) | (0.01) |
Common Equity (Total) |
18.41 | 9.71 | 12.20 | 14.22 | (11.01) | (0.01) |
Shareholders Equity (Total) |
18.41 | 9.71 | 12.20 | 14.22 | (11.01) | (0.01) |
Shareholders Equity and Liabilities (Total) |
31.71 | 18.61 | 19.19 | 20.41 | 6.66 | — |
Shares (Common) |
25.68 | 19.50 | 17.42 | 15.19 | 4.51 | — |
Shareholders Equity (Tangible) |
18.41 | 9.71 | 12.20 | 14.22 | (11.01) | (0.01) |
Net Debt |
(31.63) | (18.53) | (19.13) | (19.99) | (5.74) | — |
In millions of $ except per-share values · columns are period end dates · fundamentals updated 6 Nov 2026